Levothyroxine and Afatinib: Interaction Details

Brand names
Afatinib
Gilotrif
Levothyroxine
Levo-TLevoxylSynthroid +7 more
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Levothyroxine

Brand names
  • Levo-T
  • Levoxyl
  • Synthroid
  • Tirosint
  • Unithroid
  • Levothroid
  • Euthyrox
  • Thyquidity
  • Ermeza
  • Tirosint SOL

What Happens When You Take Levothyroxine With Afatinib

What can happen when they are taken together (rated Moderate)

Increased risk of hypothyroidism

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Taking tyrosine kinase together with levothyroxine can raise the likelihood of hypothyroidism, so TSH levels in these patients warrant close monitoring.21 In patients who have undergone thyroidectomy and are maintained on levothyroxine, starting imatinib has led to raised thyrotropin (TSH) levels along with hypothyroid symptoms.

How this interaction occurs is not precisely known, although one proposed explanation is that imatinib, in a manner comparable to rifAMPin, induces levothyroxine , which in turn drives serum TSH upward. For this reason, raising the levothyroxine dose is advisable when imatinib is started in hypothyroid patients receiving levothyroxine replacement, particularly those who have had a thyroidectomy.

These patients should be watched for hypothyroid signs and symptoms, with serum thyroxine and TSH assessed on a routine basis. Doubling the levothyroxine dose prior to beginning imatinib may be considered.3

The Levothyroxine and Afatinib Interaction, Explained

Afatinib (Gilotrif) is a cancer medicine in a group called tyrosine kinase . Medicines in this group have been linked to a higher chance of an underactive thyroid, even in people already taking levothyroxine. This means your levothyroxine dose might not be quite enough over time. This usually develops slowly, over weeks or months, so you might notice feeling more tired, cold, sluggish, or constipated, or gaining weight.

The good news is this is very manageable. Your care team can check your thyroid with simple blood tests and adjust your levothyroxine dose if needed. Keep taking both as prescribed and let your pharmacist or doctor know if you notice these symptoms.

Interaction: Tyrosine kinase (TKIs), including afatinib, may increase the risk of hypothyroidism in levothyroxine-treated patients. Onset is delayed; evidence is rated probable, largely extrapolated from TKI class data.

  • Mechanism: Unknown. For imatinib, of levothyroxine (rifampin-like) with rising TSH has been postulated, particularly in post-thyroidectomy patients. Afatinib-specific magnitude is not established.
  • Direction: Reduced effective levothyroxine response (elevated TSH, hypothyroid symptoms).
  • Management: Closely monitor TSH (and free T4) after afatinib initiation and periodically thereafter; titrate levothyroxine individually. Empiric levothyroxine dose increases have been described with imatinib, not specifically afatinib.

See the 3 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Levothyroxine and Afatinib Interact

The likely mechanism

Unknown

“Unknown” here means the studies and labels behind this record do not say how the interaction happens. It does not mean the interaction is unlikely.

How Drug Interactions Work Six short figures, about a minute: how one drug can raise or lower another’s level, or add to or cancel its effect. See how it works 

How to Manage the Levothyroxine and Afatinib Interaction

Your care team can manage this interaction with monitoring and, if needed, dose adjustments.

  • What your team may do: check your thyroid levels (TSH) more closely after you start afatinib and over time. If your levels change, your levothyroxine dose may need to be adjusted and individualized by your care team.
  • What you can do: keep taking both medicines exactly as prescribed. Tell your pharmacist or doctor if you notice unusual tiredness, feeling cold, constipation, dry skin, or weight gain.
  • Make sure everyone on your care team, including your cancer doctor, knows you take levothyroxine.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Levothyroxine or Afatinib need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there anything you'd monitor while I'm on both?

Literature Reports

1 report from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Imatinib induces hypothyroidism in patients receiving levothyroxine

    In patients who had undergone thyroidectomy and were maintained on levothyroxine, hypothyroid symptoms emerged after imatinib therapy was started. Eleven patients (n=11) with stromal tumor and medullary thyroid carcinoma received imatinib for an average of 6 months.

    Of these, 8 had undergone total thyroidectomy and were also taking levothyroxine, while 3 patients retained the thyroid in situ; all were euthyroid prior to imatinib treatment. On average within 2 weeks of starting imatinib, thyrotropin (TSH) levels rose to 384%+/-228% of the upper limit.

    Mean free thyroxine (fT4) and free tri-iodothyronine (fT3) values fell to 59% +/- 17% and 63% +/- 4% of the respective upper limits for fT4 and fT3, yet stayed within the reference range. These changes were seen exclusively in the post-thyroidectomy patients, whereas those with a normally functioning thyroid stayed euthyroid after imatinib was initiated.

    In all post-thyroidectomy patients, the levothyroxine dose was increased stepwise to an average of 206% (range, 100% to 350%) of the pre-imatinib dose, but this reversed hypothyroidism in only 3 patients. For the other post-thyroidectomy patients, hypothyroid symptoms resolved once imatinib was discontinued. The precise mechanism underlying this imatinib and levothyroxine interaction was not established; however, the investigators excluded other likely causes of hypothyroidism and proposed that imatinib of levothyroxine may account for the hypothyroidism observed.3

Levothyroxine and Afatinib: Common Questions

How serious is the Levothyroxine and Afatinib interaction?

It is rated moderate. Can be significant — usually manageable with monitoring.

How is the Levothyroxine and Afatinib interaction managed?

Your care team can manage this interaction with monitoring and, if needed, dose adjustments. What your team may do: check your thyroid levels (TSH) more closely after you start afatinib and over time. If your levels change, your levothyroxine dose may need to be adjusted and individualized by your care team. What you can do: keep taking both medicines exactly as prescribed. Tell your pharmacist or… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "delayed". Effects tend to build up gradually over days to weeks.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Ask About the Levothyroxine and Afatinib Interaction

Ask in your own words about taking Levothyroxine and Afatinib together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (3)

  1. Product Information: LEVO-T® oral tablets, levothyroxine sodium oral tablets. Neolpharma Inc, Caguas, PR, 2026. DailyMed
  2. Product Information: SYNTHROID(R) oral tablets, levothyroxine sodium oral tablets. AbbVie Inc (per FDA), North Chicago, IL, 2024. DailyMed
  3. de Groot JWB, Zonnenberg BA, Plukker JTM, et al: Imatinib induces hypothyroidism in patients receiving levothyroxine. Clin Pharmacol Ther 2005; 78:433-438. PubMed
Was this write-up helpful?

Other Serious Interactions of Levothyroxine and Afatinib

Also serious with Afatinib

Also serious with Levothyroxine

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Levothyroxine

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring.
  • Moderate Can be significant — usually manageable with monitoring. This interaction.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven. This interaction.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks. This interaction.
  • UnspecifiedThe timing of this interaction is not well characterized.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.